For example, INSL5, as a peptide hormone, after intraperitoneal injection, leads to significant changes in inflammatory factors such as IL-5, IL-7, M-CSF, IL-15 and IL-27 [43], and these inflammatory signals typically play a regulatory role in CAD. This evidence concerns the gene IL5 and coronary artery disorder.